Alberto S. Pappo

Hematology | Oncology

262 Danny Thomas Pl
Memphis, TN 38105

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 183 publications

Adult Sarcomas with NTRK Fusions: Clinicopathologic and Genomic Heterogeneity.

Adult Sarcomas with NTRK Fusions: Clinicopathologic and Genomic Heterogeneity.

Journal: Cancers

Published: July 04, 2026

NCCN Guidelines® Insights: Soft Tissue Sarcoma, Version 1.2025.

NCCN Guidelines® Insights: Soft Tissue Sarcoma, Version 1.2025.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: February 11, 2026

Pathway for the Development of ATR Inhibitors in Pediatric Malignancies: An ACCELERATE Multistakeholder Analysis.

Pathway for the Development of ATR Inhibitors in Pediatric Malignancies: An ACCELERATE Multistakeholder Analysis.

Journal: JCO precision oncology

Published: January 15, 2026

Pharmacogenetic variants in the molecular characterization initiative: a report from the children's oncology group.

Pharmacogenetic variants in the molecular characterization initiative: a report from the children's oncology group.

Journal: Journal of the National Cancer Institute

Published: December 17, 2025

Comparing Whole-Body Diffusion-weighted MRI to Conventional Imaging: Staging Pediatric Bone and Soft-Tissue Sarcomas.

Comparing Whole-Body Diffusion-weighted MRI to Conventional Imaging: Staging Pediatric Bone and Soft-Tissue Sarcomas.

Journal: Radiology. Imaging cancer

Published: September 19, 2025

Belzutifan for HIF2A-Related Pheochromocytoma and Paraganglioma: A Retrospective Study of Real-World Data.

Belzutifan for HIF2A-Related Pheochromocytoma and Paraganglioma: A Retrospective Study of Real-World Data.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Published: August 21, 2025

Paediatric Strategy Forum for medicinal product development of agents targeting GD2 ganglioside in children and adolescents with cancer.

Paediatric Strategy Forum for medicinal product development of agents targeting GD2 ganglioside in children and adolescents with cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 29, 2025

Parent and Participant Perspectives on Research Biopsies in Pediatric Solid Malignancies.

Parent and Participant Perspectives on Research Biopsies in Pediatric Solid Malignancies.

Journal: Pediatric blood & cancer

Published: July 25, 2025

ESFT13: A Phase II Study Evaluating the Addition of Window and Maintenance Therapy to a Standard Chemotherapy Backbone for the Treatment of High-Risk Ewing Sarcoma.

ESFT13: A Phase II Study Evaluating the Addition of Window and Maintenance Therapy to a Standard Chemotherapy Backbone for the Treatment of High-Risk Ewing Sarcoma.

Journal: Cancers

Published: July 14, 2025

The Evolving Landscape of Sarcomas.

The Evolving Landscape of Sarcomas.

Journal: Hematology/oncology clinics of North America

Published: June 06, 2025

Paediatric strategy forum for medicinal product development of cyclin-dependent kinase inhibitors in children and adolescents ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug Administration.

Paediatric strategy forum for medicinal product development of cyclin-dependent kinase inhibitors in children and adolescents ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug Administration.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 10, 2025

Acute cardiotoxicity in pediatric and adolescent patients with solid tumors treated with tyrosine kinase inhibitors.

Acute cardiotoxicity in pediatric and adolescent patients with solid tumors treated with tyrosine kinase inhibitors.

Journal: Cancer

Published: March 10, 2025

Showing 1-12 of 183

Last Updated: 09/26/2026